Learn more about our Payment & Health Care Delivery Policy work.
AdvaMed, the Medtech Association, released a new report, done in collaboration with Health Management Associates, that highlights the need for new resources to support the work of the Coverage and…
This report focuses on coverage for devices and issues related to procedural delays, the lack of transparency in Medicare’s National Coverage Determination process, the use of Coverage with Evidence Development,…
Today, AdvaMed, the Medtech Association, announced that Carol Blackford has joined the organization as Executive Vice President of Payment and Health Care Delivery Policy. She will lead the AdvaMed team…
This week, AdvaMed, the Medtech Association, praised ongoing legislative efforts to develop a pathway for Medicare coverage for FDA-approved breakthrough technologies during a House Committee on Energy and Commerce Subcommittee…
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the recently issued proposed Transitional Coverage for Emerging Technologies (TCET) rule.
This AdvaMed position statement is intended to provide clarity about the transition away from the acronyms NDC/NHRIC to NRC, including rationale and implications.
AdvaMed’s medtech priorities for the 118th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Learn the basic principles of how medical technologies are covered and paid by insurers and the challenges medtech companies face.
This publication series explores “Software as a Medical Device (SaMD),” its challenges and the ways regulatory bodies try to address them, as well as the expected development of regulations related…
AdvaMed launched a Strategic Value Initiative to develop principles and an approach for assessing the value of medical technologies that can be adopted by medtech companies, health systems, payers, and…